Please login to the form below

Not currently logged in

BMS claims a win in mid-stage NASH trial

Bristol-Myers Squibb (BMS) building

Its new liver disease therapy reduces fatty deposits and improves blood lipid profiles

AbbVie's PARP inhibitor veliparib fails to deliver

Phase III trials show no increase in clinical benefit

Circassia exits allergy R&D after placebo effect strikes again

Abandons phase IIb trial of house dust mite allergy candidate

Microbiome specialist Rebiotix chalks up C. diff trial success

Drug therapy can prevent recurrent infections

Neurocrine bags FDA approval for first tardive dyskinesia drug

Ingrezza edges ahead of Teva’s rival drug Austedo

Apexigen and BMS team up for lung cancer immunotherapy trial

Bristol Myers Squibb logoOpdivo and APX005M used together may improve immune reaction

Roche’s Alecensa beats Xalkori as first-line lung cancer therapy

Roche Basel SwitzerlandData shows ALK inhibitor reduces risk of disease worsening

Allergan pushes on with Botox for depression

Allergan BotoxDecision comes despite less than stellar clincial data

Merck, Pfizer get first OK for checkpoint inhibitor avelumab

Merck KGaAFDA approval for rare skin cancer drug

Riding the wave of digital disruption

The challenges and rewards of meeting consumer expectations

  • Real-world evidence

    Companies are now recruiting high-level executives to lead well-resourced RWE teams as industry looks to reshape the future

  • The future of biotech

    What impact will the sector, and its R&D performance, have on pharma?

Featured jobs

Subscribe to our email news alerts


Add my company

Specialising in medical device market research, our approach is people-centric and we thrive on making connections with clients and research...

Latest intelligence

Can you access your own content?
The rapid development of multichannel communication opens new opportunities to provide high-value experiences for healthcare professionals and gives you more places than ever to tell your product story. But unless...
How will capitated budgets affect NHS spending?
Sue Thomas and Paul Midgley, of Wilmington Healthcare, assess the implications of a single budget covering all the physical, mental and social care needs of patients in an STP...
Dissecting adherence to personalise patient support
Across the healthcare and pharmaceutical industries, the initiatives to better understand the patient journey and lower healthcare costs have been growing in magnitude. One solution that has repeatedly been raised...